Business
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June 26, 2026 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2026. Medexus expects to file its financial statements and MD&A after markets close on June 25, 2026.To participate in the call, please dial the following numbers:888-506-0062 (toll-free) for Canadian...
About this update from Medexus Pharmaceuticals Inc.
[{"type":"text","content":"Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June 26, 2026 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2026. Medexus expects to file its financial statements and MD&A after markets close on June 25, 2026.","length":406,"tagName":"p"},{"type":"text","content":"To participate in the call, please dial the following numbers:","length":62,"tagName":"p"},{"type":"text","content":"888-506-0062 (toll-free) for Canadian and U.S. callers+1 973-528-0011 for international callers","length":96,"tagName":"p","attribs":{}},{"type":"text","content":"Access code: 515731","length":19,"tagName":"p","attribs":{}},{"type":"text","content":"A live webcast of the call will be available on the Investors section of Medexus's corporate website or at the following link:","length":130,"tagName":"p"},{"type":"text","content":"https://www.webcaster5.com/Webcast/Page/2010/54174","length":50,"tagName":"p","attribs":{}},{"type":"text","content":"A replay of the call will be available approximately one hour following the end of the call through Friday, July 10, 2026. To access the replay, please dial the following numbers -","length":180,"tagName":"p"},{"type":"text","content":"877-481-4010 for Canadian and U.S. callers+1 919-882-2331 for international callers","length":84,"tagName":"p","attribs":{}},{"type":"text","content":"Conference ID: 54174","length":20,"tagName":"p","attribs":{}},{"type":"text","content":"A replay of the webcast will be available on the Investors section of Medexus's corporate website until Saturday, June 26, 2027.","length":132,"tagName":"p"},{"type":"text","content":"About Medexus","length":13,"tagName":"p"},{"type":"text","content":"Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of hematology and hemato-oncology and rheumatology and allergy. For more information about Medexus and its product portfolio, please see the company's corporate website at www.medexus.com and its filings on SEDAR+ at www.sedarplus.ca.","length":473,"tagName":"p"},{"t...